efavirenz and Cardiotoxicity

efavirenz has been researched along with Cardiotoxicity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gupta, SK; Kamendulis, LM; Liu, Z; Slaven, JE	1

Trials

1 trial(s) available for efavirenz and Cardiotoxicity

Article	Year
A randomized, controlled trial of the effect of rilpivirine versus efavirenz on cardiovascular risk in healthy volunteers. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:10 Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Bilirubin; Biomarkers; Cardiotoxicity; Cardiovascular Diseases; Cardiovascular System; Cyclopropanes; F2-Isoprostanes; Healthy Volunteers; Humans; Oxidative Stress; Rilpivirine; Time Factors	2015

Article

Year

A randomized, controlled trial of the effect of rilpivirine versus efavirenz on cardiovascular risk in healthy volunteers.

The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:10

Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Bilirubin; Biomarkers; Cardiotoxicity; Cardiovascular Diseases; Cardiovascular System; Cyclopropanes; F2-Isoprostanes; Healthy Volunteers; Humans; Oxidative Stress; Rilpivirine; Time Factors

2015